STONY BROOK, NY
-- (Marketwired)
-- 11/21/16
Applied DNA Sciences (Applied DNA), Inc. (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting, authentication, genotyping and anti-theft technologies, today announced that it will issue its fourth quarter and fiscal full year 2016 financial results on Tuesday, December 6, 2016 after market close.
The company will conduct a conference call and webcast to review its results the same day at 4:30 pm ET/1:30pm PT. Applied DNA President and CEO, Dr. James Hayward, and Chief Financial Officer, Beth Jantzen, plan to discuss the company's performance and achievements and outline key ongoing and future business initiatives on the conference call. Management's remarks will be followed by a question-and-answer session. The conference call and webcast will be accompanied by a PowerPoint presentation, which will be made available for download on the Company's website at the start of the call.
To Participate:
- Participant Toll Free: 1-844-887-9402
- Participant Toll: 1-412-317-6798
- Please ask to be joined to the Applied DNA Sciences earnings call
Live webcast: https://services.choruscall.com/links/apdn161206.html
Replay (available 1 hour following the conclusion of the live call):
About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016, May 12, 2016 and August 11, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contacts:
Debbie Bailey
631-240-8817
debbie.bailey@adnas.com
Sanjay M. Hurry
LHA
212-838-3777
shurry@lhai.com
web: www.adnas.com
twitter: @APDN
© 2024 Canjex Publishing Ltd. All rights reserved.